2.12: Lipid-regulating drugs

Part of chapter 2 Cardiovascular System

High-level prescribing trends for Lipid-regulating drugs (BNF section 2.12) across Alnwick Medical Group for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Acipimox (0212000A0)
Alirocumab (0212000AI)
Atorvastatin (0212000B0)
Bempedoic acid (0212000AK)
Bempedoic acid/Ezetimibe (0212000AL)
Bezafibrate (0212000D0)
Cerivastatin (0212000C0)
Ciprofibrate (021200010)
Colesevelam hydrochloride (0212000AD)
Colestipol hydrochloride (0212000K0)
Colestyramine (0212000F0)
Evolocumab (0212000AH)
Ezetimibe (0212000L0)
Fenofibrate (0212000P0)
Fenofibrate/simvastatin (0212000AJ)
Fluvastatin sodium (0212000M0)
Gemfibrozil (0212000Q0)
Icosapent (0212000AN)
Inclisiran (0212000AM)
Ispaghula husk (0212000J0)
Nicotinic acid (0212000U0)
Nicotinic acid/laropiprant (0212000AE)
Omega-3-acid ethyl esters (0212000AB)
Omega-3 marine triglycerides (0212000V0)
Other Lipid-Regulating Preps (021200000)
Policosanol (0212000AG)
Pravastatin sodium (0212000X0)
Rosuvastatin calcium (0212000AA)
Simvastatin (0212000Y0)
Simvastatin and ezetimibe (0212000AC)
Feedback